Latest News of LGND
Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings
By Yahoo! Finance |
1 month ago
Ligand Pharmaceuticals Inc (LGND) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
By Yahoo! Finance |
1 month ago
The past three years for Ligand Pharmaceuticals (NASDAQ:LGND) investors has not been profitable
By Yahoo! Finance |
6 months ago